Renal Outcomes Associated with the Use of Non-Insulin Antidiabetic Pharmacotherapy: A Review of Current Evidence and Recommendations.

Mohammed Hassan Elnaem Noha O MansourAbdulrahman Fata NahasMohamed A Baraka Ramadan Mohamed Elkalmi Ejaz Cheema

Published in: International journal of general medicine (2020)

More than half of the studies included in this review supported the renoprotective effects associated with the use of AD medications, particularly GLP-1A, SGLT2i, and some of the DPP4i. Further studies involving patients with various stages of chronic kidney disease (CKD) are required to compare AD medications' renal effects, particularly the newer agents.

Keyphrases

chronic kidney disease
end stage renal disease
type diabetes
case control
clinical practice
smoking cessation
metabolic syndrome
glycemic control
insulin resistance